Mycophenolate 500

Mycophenolate (CellCept^®, Myfortic^®) is a prescription medication approved to prevent organ rejection following a transplant. There are two different forms of mycophenolate: mycophenolate mofetil (approved for use after a heart, kidney, or liver transplant) and mycophenolate sodium (approved for use after a kidney transplant only).

Some of the strengths and forms in which mycophenolate is available include:

Mycophenolate mofetil 500 mg tablets
Mycophenolate mofetil 500 mg intravenous, containing 6 mg per mL when reconstituted as directed
Mycophenolate sodium 360 mg tablets.

Your healthcare provider will decide which type is right for you, based on your age, current medical conditions, and other factors.

(For more details on the different forms of this drug, click Mycophenolate Dosage. This article discusses the dosing guidelines for the different types of mycophenolate in both children and adults, and offers tips to ensure a safe, effective treatment process.)